Medicover releases Q1 results
Reports 10.3% organic revenue growth to €624.2m and 15.4% adjusted EBITDA increase. Highlights include hospital openings, tech milestones, and a clinical trials partnership.
See the latest news and media coverage for Medicover. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of diagnostic and healthcare services
medicover.comLast updated
In short: Medicover reported strong Q1 2026 financial growth and explored a potential sale or IPO of its Indian operations while expanding global services.
Reports 10.3% organic revenue growth to €624.2m and 15.4% adjusted EBITDA increase. Highlights include hospital openings, tech milestones, and a clinical trials partnership.
The report highlights expansions, diagnostic improvements, digital scaling, sustainability progress, and exceeded financial targets. Teams delivered high-quality care across 19 countries.
The collaboration strengthens multinational clinical trial capabilities across Europe, U.S., and Asia-Pacific through coordinated operations and joint marketing.
CEO and CFO present new financial targets for 2026-2028, emphasizing sustainable growth and operational performance. Over 100 participants join.
Empower India Limited Expands into Digital Solar Solutions to Capture India's Fast-Growing Renewable Energy Market ...
Medicover is preparing an IPO of its Indian operations - but now the company reveals it is in discussions with private equity giant KKR about a...
The Shareholders have found a new stock for their so-called small-cap portfolio. At the same time, they take the opportunity to sell off one of the recent years' big winners...
Review the current Medicover AB Class B (MCOV B:XSTO) dividend yield and history to decide if MCOV B is the best investment for you.
Track Medicover and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Medicover and other trending companies.